BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11793984)

  • 1. Nitric oxide synthase inhibition decreases output of hepatic insulin sensitizing substance (HISS), which is reversed by SIN-1 but not by nitroprusside.
    Guarino MP; Correia NC; Raposo J; Macedo MP
    Proc West Pharmacol Soc; 2001; 44():25-6. PubMed ID: 11793984
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver.
    Guarino MP; Correia NC; Lautt WW; Macedo MP
    Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G527-32. PubMed ID: 15331351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action.
    Guarino MP; Afonso RA; Raimundo N; Raposo JF; Macedo MP
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G588-94. PubMed ID: 12466146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of hepatic nitric oxide synthase causes insulin resistance.
    Sadri P; Lautt WW
    Am J Physiol; 1999 Jul; 277(1):G101-8. PubMed ID: 10409156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake.
    Moore MC; Dicostanzo CA; Smith MS; Farmer B; Rodewald TD; Neal DW; Williams PE; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E768-77. PubMed ID: 18212022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.
    An Z; DiCostanzo CA; Moore MC; Edgerton DS; Dardevet DP; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E300-6. PubMed ID: 18029444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide reduces organ injury and enhances regeneration of reduced-size livers by increasing hepatic arterial flow.
    Cantré D; Schuett H; Hildebrandt A; Dold S; Menger MD; Vollmar B; Eipel C
    Br J Surg; 2008 Jun; 95(6):785-92. PubMed ID: 18412296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance caused by nitric oxide synthase inhibition.
    Sadri P; Legare DJ; Lautt WW
    Proc West Pharmacol Soc; 1997; 40():19-20. PubMed ID: 9436202
    [No Abstract]   [Full Text] [Related]  

  • 9. Nitric oxide modulates ionic transport in the isolated intestine of the eel, Anguilla anguilla.
    Trischitta F; Pidalà P; Faggio C
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Oct; 148(2):368-73. PubMed ID: 17604669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of the NO-cyclic GMP pathway in rofecoxib-induced antinociception.
    Déciga-Campos M; López-Muñoz FJ
    Proc West Pharmacol Soc; 2003; 46():165-7. PubMed ID: 14699919
    [No Abstract]   [Full Text] [Related]  

  • 11. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
    Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
    Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone production in bovine luteal cells treated with drugs that modulate nitric oxide production.
    Jaroszewski JJ; Bogacki M; Skarzynski DJ
    Reproduction; 2003 Mar; 125(3):389-95. PubMed ID: 12611602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microinjection of the nitric oxide synthase inhibitor L-NAME into the lateral basal forebrain alters the sleep/wake cycle of the rat.
    Monti JM; Jantos H
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):239-47. PubMed ID: 14751418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordination of calcium signalling by endothelial-derived nitric oxide in the intact liver.
    Patel S; Robb-Gaspers LD; Stellato KA; Shon M; Thomas AP
    Nat Cell Biol; 1999 Dec; 1(8):467-71. PubMed ID: 10587641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic parasympathetic role in insulin resistance on an animal model of hypertension.
    Ribeiro RT; Afonso RA; Macedo MP
    Metabolism; 2007 Feb; 56(2):227-33. PubMed ID: 17224337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosterone suppresses insulin- and NO-stimulated muscle glucose uptake in broiler chickens (Gallus gallus domesticus).
    Zhao JP; Lin H; Jiao HC; Song ZG
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Apr; 149(3):448-54. PubMed ID: 19000934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective hepatic nitric oxide action results in HISS-dependent insulin resistance in spontaneously hypertensive rats.
    Afonso RA; Ribeiro RT; Macedo MP
    Proc West Pharmacol Soc; 2004; 47():103-4. PubMed ID: 15633625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of intraspinal L-NOARG or SIN-1 on the control by descending pathways of incisional pain in rats.
    Kina VA; Villarreal CF; Prado WA
    Life Sci; 2005 Mar; 76(17):1939-51. PubMed ID: 15707877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxycholyltaurine-induced vasodilation of rodent aorta is nitric oxide- and muscarinic M(3) receptor-dependent.
    Khurana S; Yamada M; Wess J; Kennedy RH; Raufman JP
    Eur J Pharmacol; 2005 Jul; 517(1-2):103-10. PubMed ID: 15964566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide does not affect histamine release from rat peritoneal mast cells.
    Lau HY; Chow SM
    Inflamm Res; 1999 Apr; 48 Suppl 1():S27-8. PubMed ID: 10350147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.